Ignite Creation Date:
2024-05-05 @ 4:44 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00303472
Status:
COMPLETED
Last Update Posted:
2013-12-16
First Post:
2006-03-16
Brief Title:
Determination of Safe Dose of Romiplostim AMG 531 in Patients With Myelodysplastic Syndromes MDS
Sponsor:
Amgen
Organization:
Amgen
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-02
Start Date Type:
None
Primary Completion Date:
2008-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-05
Completion Date Type:
ACTUAL
First Submit Date:
2006-03-16
First Submit QC Date:
March 16 2006
Study First Post Date:
2006-03-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2010-11-19
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-11-21
Last Update Post Date:
2013-12-16
Last Update Post Date Type:
ESTIMATED